We're committed to providing you with the very best cancer care, and your safety continues to be a top priority. With this in mind, we’ve put in place many new procedures, including a limited visitor policy. This is just one more way of ensuring your safety and that of our staff. Read more
MD, Harvard Medical School; MPH, Harvard School of Public Health
Internal Medicine, Beth Israel Deaconess Medical Center
I am a board-certified internal medicine physician who specializes in caring for people who are hospitalized at Memorial Sloan Kettering Cancer Center. I treat conditions such as heart failure, pneumonia, sepsis, and renal failure, as well as complications related to cancer and its treatment.
I am committed to delivering compassionate, patient-centered, and evidence-based care. My areas of research have focused on quality improvement and treatment outcomes. In addition to direct patient care and research, I enjoy teaching medical students and residents.
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Joseph S. Wallins discloses the following relationships and financial interests:
Apple Inc Ownership / Equity Interests
Tembo Health Fiduciary Role/Position
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2019 through disclosure submission in spring 2020). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].